Wealth Architects LLC Makes New $763,000 Investment in Astera Labs, Inc. (NASDAQ:ALAB)

Wealth Architects LLC bought a new stake in shares of Astera Labs, Inc. (NASDAQ:ALABFree Report) during the fourth quarter, Holdings Channel.com reports. The fund bought 5,757 shares of the company’s stock, valued at approximately $763,000.

A number of other institutional investors have also recently modified their holdings of the business. SlateStone Wealth LLC grew its position in shares of Astera Labs by 15.0% during the 4th quarter. SlateStone Wealth LLC now owns 18,400 shares of the company’s stock valued at $2,437,000 after acquiring an additional 2,400 shares during the period. CV Advisors LLC acquired a new stake in Astera Labs in the 4th quarter worth about $265,000. Envestnet Portfolio Solutions Inc. purchased a new position in Astera Labs in the 4th quarter worth approximately $599,000. Natixis Advisors LLC purchased a new position in Astera Labs in the 4th quarter worth approximately $2,871,000. Finally, Commonwealth Equity Services LLC purchased a new position in Astera Labs in the 4th quarter worth approximately $1,693,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Astera Labs Stock Up 10.5 %

NASDAQ:ALAB opened at $72.18 on Monday. The company has a fifty day simple moving average of $97.61 and a two-hundred day simple moving average of $88.63. The company has a market cap of $11.70 billion and a price-to-earnings ratio of -41.72. Astera Labs, Inc. has a 52 week low of $36.22 and a 52 week high of $147.39.

Astera Labs (NASDAQ:ALABGet Free Report) last posted its quarterly earnings results on Monday, February 10th. The company reported $0.10 EPS for the quarter, missing the consensus estimate of $0.26 by ($0.16). Astera Labs had a negative return on equity of 10.40% and a negative net margin of 21.05%. On average, analysts expect that Astera Labs, Inc. will post 0.34 EPS for the current year.

Analyst Ratings Changes

A number of research analysts have weighed in on the stock. Morgan Stanley decreased their target price on shares of Astera Labs from $142.00 to $114.00 and set an “equal weight” rating on the stock in a research note on Tuesday, January 28th. Northland Securities raised shares of Astera Labs from a “market perform” rating to an “outperform” rating and set a $120.00 price target on the stock in a research report on Tuesday, January 28th. Craig Hallum lifted their price target on shares of Astera Labs from $105.00 to $125.00 and gave the company a “buy” rating in a research report on Tuesday, February 11th. Northland Capmk raised shares of Astera Labs from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, January 28th. Finally, Barclays lifted their price target on shares of Astera Labs from $87.00 to $135.00 and gave the company an “overweight” rating in a research report on Friday, January 17th. One research analyst has rated the stock with a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Buy” and a consensus price target of $112.77.

Check Out Our Latest Stock Report on ALAB

Insider Buying and Selling

In related news, CFO Michael Truett Tate sold 125,800 shares of the business’s stock in a transaction on Wednesday, February 26th. The shares were sold at an average price of $82.53, for a total transaction of $10,382,274.00. Following the completion of the transaction, the chief financial officer now owns 244,242 shares in the company, valued at approximately $20,157,292.26. The trade was a 34.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Jitendra Mohan sold 350,680 shares of the business’s stock in a transaction on Wednesday, February 19th. The stock was sold at an average price of $89.51, for a total transaction of $31,389,366.80. Following the transaction, the chief executive officer now owns 2,353,655 shares of the company’s stock, valued at approximately $210,675,659.05. The trade was a 12.97 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 570,990 shares of company stock worth $50,242,702.

Astera Labs Profile

(Free Report)

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

Read More

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALABFree Report).

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.